{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T19:27:04Z","timestamp":1769628424654,"version":"3.49.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ital J Pediatr"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s13052-016-0302-3","type":"journal-article","created":{"date-parts":[[2016,11,3]],"date-time":"2016-11-03T11:41:12Z","timestamp":1478173272000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Long-term safety and efficacy of Omnitrope\u00ae, a somatropin biosimilar, in children requiring growth hormone treatment: Italian interim analysis of the PATRO Children study"],"prefix":"10.1186","volume":"42","author":[{"given":"Lorenzo","family":"Iughetti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gianluca","family":"Tornese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Elisabeth","family":"Street","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Flavia","family":"Napoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Giavoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franco","family":"Antoniazzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"Stagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caterina","family":"Luongo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Azzolini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Letizia","family":"Ragusa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gianni","family":"Bona","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clara","family":"Zecchino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tommaso","family":"Aversa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Persani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Guazzarotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emiliano","family":"Zecchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Pietropoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"Zucchini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,11,3]]},"reference":[{"issue":"6","key":"302_CR1","doi-asserted-by":"crossref","first-page":"580","DOI":"10.4158\/EP.15.6.580","volume":"15","author":"DM Cook","year":"2009","unstructured":"Cook DM, Yuen KC, Biller BM, Kemp SF, Vance ML. American Association of Clinical Endocrinologists medical guidelines for clinical practice for growth hormone use in growth hormone-deficient adults and transition patients - 2009 update: executive summary of recommendations. Endocr Pract. 2009;15(6):580\u20136.","journal-title":"Endocr Pract"},{"issue":"11","key":"302_CR2","first-page":"3990","volume":"85","author":"Growth Hormone Research Society","year":"2000","unstructured":"Growth Hormone Research Society. Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: summary statement of the GH Research Society. J Clin Endocrinol Metab. 2000;85(11):3990\u20133.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"302_CR3","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1530\/eje.1.01829","volume":"152","author":"PE Clayton","year":"2005","unstructured":"Clayton PE, Cuneo RC, Juul A, Monson JP, Shalet SM, Tauber M. Consensus statement on the management of the GH-treated adolescent in the transition to adult care. Eur J Endocrinol. 2005;152(2):165\u201370.","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"302_CR4","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1210\/jc.2006-1374","volume":"92","author":"CA Bondy","year":"2007","unstructured":"Bondy CA. Care of girls and women with Turner syndrome: a guideline of the Turner Syndrome Study Group. J Clin Endocrinol Metab. 2007;92(1):10\u201325.","journal-title":"J Clin Endocrinol Metab"},{"issue":"6 Pt 1","key":"302_CR5","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1542\/peds.111.6.1253","volume":"111","author":"PA Lee","year":"2003","unstructured":"Lee PA, Chernausek SD, Hokken-Koelega AC, Czernichow P. International Small for Gestational Age Advisory Board consensus development conference statement: management of short children born small for gestational age, April 24-October 1, 2001. Pediatrics. 2003;111(6 Pt 1):1253\u201361.","journal-title":"Pediatrics"},{"issue":"7","key":"302_CR6","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1007\/s00467-006-0020-y","volume":"21","author":"JD Mahan","year":"2006","unstructured":"Mahan JD, Warady BA. Assessment and treatment of short stature in pediatric patients with chronic kidney disease: a consensus statement. Pediatr Nephrol. 2006;21(7):917\u201330.","journal-title":"Pediatr Nephrol"},{"issue":"11","key":"302_CR7","doi-asserted-by":"crossref","first-page":"4183","DOI":"10.1210\/jc.2008-0649","volume":"93","author":"AP Goldstone","year":"2008","unstructured":"Goldstone AP, Holland AJ, Hauffa BP, Hokken-Koelega AC, Tauber M. Recommendations for the diagnosis and management of Prader-Willi syndrome. J Clin Endocrinol Metab. 2008;93(11):4183\u201397.","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"302_CR8","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1007\/BF03346352","volume":"30","author":"T Romer","year":"2007","unstructured":"Romer T, Peter F, Saenger P, Starzyk J, Koehler B, Korman E, et al. Efficacy and safety of a new ready-to-use recombinant human growth hormone solution. J Endocrinol Invest. 2007;30(7):578\u201389.","journal-title":"J Endocrinol Invest"},{"issue":"10","key":"302_CR9","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1007\/s12325-011-0063-8","volume":"28","author":"J L\u00f3pez-Siguero","year":"2011","unstructured":"L\u00f3pez-Siguero J, Borras Perez MV, Balser S, Khan-Boluki J. Long-term safety and efficacy of the recombinant human growth hormone Omnitrope\u00ae in the treatment of Spanish growth hormone deficient children: results of a phase III study. Adv Ther. 2011;28(10):879\u201393.","journal-title":"Adv Ther"},{"issue":"4","key":"302_CR10","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.3349\/ymj.2014.55.4.1042","volume":"55","author":"Y Kim","year":"2014","unstructured":"Kim Y, Hong JW, Chung YS, Kim SW, Cho YW, Kim JH, et al. Efficacy and safety of sustained-release recombinant human growth hormone in Korean adults with growth hormone deficiency. Yonsei Med J. 2014;55(4):1042\u20138.","journal-title":"Yonsei Med J"},{"issue":"1","key":"302_CR11","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/s40200-014-0115-0","volume":"13","author":"O Tabatabaei-Malazy","year":"2014","unstructured":"Tabatabaei-Malazy O, Mohajeri-Tehrani MR, Heshmat R, Taheri E, Shafiee G, Razzaghy-Azar M, et al. Efficacy and safety of Samtropin recombinant human growth hormone; a double-blind randomized clinical trial. J Diabetes Metab Disord. 2014;13(1):115.","journal-title":"J Diabetes Metab Disord"},{"issue":"2","key":"302_CR12","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1007\/s12325-015-0181-9","volume":"32","author":"V Borr\u00e1s P\u00e9rez","year":"2015","unstructured":"Borr\u00e1s P\u00e9rez V, L\u00f3pez-Siguero JP, Mart\u00ednez G, Corripio R, Fern\u00e1ndez JM, Labarta JI, et al. A follow-up study to monitor adult height among Spanish children with growth hormone deficiency who received biosimilar human recombinant growth hormone (Omnitrope\u00ae) during a phase III clinical trial. Adv Ther. 2015;32(2):148\u201356.","journal-title":"Adv Ther"},{"key":"302_CR13","volume-title":"Omnitrope\u00ae summary of product characteristics","author":"European Medicines Agency","year":"2015","unstructured":"European Medicines Agency. Omnitrope\u00ae summary of product characteristics. 2015. Available from URL: http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Product_Information\/human\/000607\/WC500043695.pdf . Accessed 19 Nov 2015."},{"issue":"6","key":"302_CR14","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1159\/000249164","volume":"72","author":"T Romer","year":"2009","unstructured":"Romer T, Saenger P, Peter F, Walczak M, Le Bouc Y, Khan-Boluki J, et al. Seven years of safety and efficacy of the recombinant human growth hormone Omnitrope in the treatment of growth hormone deficient children: results of a phase III study. Horm Res. 2009;72(6):359\u201369.","journal-title":"Horm Res"},{"issue":"1","key":"302_CR15","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/2042018813479644","volume":"4","author":"R Pf\u00e4ffle","year":"2013","unstructured":"Pf\u00e4ffle R, Schwab KO, Marginean O, Walczak M, Szalecki M, Schuck E, et al. Design of, and first data from, PATRO Children, a multicentre, noninterventional study of the long-term efficacy and safety of Omnitrope\u00ae in children requiring growth hormone treatment. Ther Adv Endocrinol Metab. 2013;4(1):3\u201311.","journal-title":"Ther Adv Endocrinol Metab"},{"issue":"Suppl 1","key":"302_CR16","first-page":"242","volume":"84","author":"R Pf\u00e4ffle","year":"2015","unstructured":"Pf\u00e4ffle R, Kanumakala S, Hoybye C, Kristrom B, Schuck E, Zabransky M, et al. Results up to January 2015 from PATRO Children, a multi-centre, non-interventional study of the long-term safety and efficacy of Omnitrope\u00ae in children requiring GH treatment. Horm Res Paediatr. 2015;84 Suppl 1:242\u20138.","journal-title":"Horm Res Paediatr"},{"issue":"3","key":"302_CR17","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/MPG.0b013e3181da213e","volume":"51","author":"E Bertino","year":"2010","unstructured":"Bertino E, Spada E, Occhi L, Coscia A, Giuliani F, Gagliardi L, et al. Neonatal anthropometric charts: the Italian neonatal study compared with other European studies. J Pediatr Gastroenterol Nutr. 2010;51(3):353\u201361.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"3","key":"302_CR18","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1136\/adc.51.3.170","volume":"51","author":"JM Tanner","year":"1976","unstructured":"Tanner JM, Whitehouse RH. Clinical longitudinal standards for height, weight, height velocity, weight velocity, and stages of puberty. Arch Dis Child. 1976;51(3):170\u20139.","journal-title":"Arch Dis Child"},{"issue":"9204","key":"302_CR19","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/S0140-6736(99)04055-6","volume":"355","author":"WS Cutfield","year":"2000","unstructured":"Cutfield WS, Wilton P, Bennmarker H, Albertsson-Wikland K, Chatelain P, Ranke MB, et al. Incidence of diabetes mellitus and impaired glucose tolerance in children and adolescents receiving growth-hormone treatment. Lancet. 2000;355(9204):610\u20133.","journal-title":"Lancet"},{"issue":"2","key":"302_CR20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1530\/EJE-15-0873","volume":"174","author":"DB Allen","year":"2015","unstructured":"Allen DB, Backeljauw P, Bidlingmaier M, Biller BM, Boguszewski M, Burman P, et al. GH safety workshop position paper: a critical appraisal of recombinant human GH therapy in children and adults. Eur J Endocrinol. 2015;174(2):1\u20139.","journal-title":"Eur J Endocrinol"},{"issue":"9","key":"302_CR21","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.2337\/diacare.23.9.1260","volume":"23","author":"EJ Boyko","year":"2000","unstructured":"Boyko EJ. Proportion of type 2 diabetes cases resulting from impaired fetal growth. Diabetes Care. 2000;23(9):1260\u20134.","journal-title":"Diabetes Care"},{"issue":"2","key":"302_CR22","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/j.1365-2265.2006.02570.x","volume":"65","author":"ME Craig","year":"2006","unstructured":"Craig ME, Cowell CT, Larsson P, Zipf WB, Reiter EO, Albertsson Wikland K, et al. Growth hormone treatment and adverse events in Prader-Willi syndrome: data from KIGS (the Pfizer International Growth Database). Clin Endocrinol (Oxf). 2006;65(2):178\u201385.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"302_CR23","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3345\/kjp.2015.58.2.41","volume":"58","author":"HW Chae","year":"2015","unstructured":"Chae HW, Kim DH, Kim HS. Growth hormone treatment and risk of malignancy. Korean J Pediatr. 2015;58(2):41\u20136.","journal-title":"Korean J Pediatr"},{"issue":"10","key":"302_CR24","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/ncpendmet0295","volume":"2","author":"AJ Swerdlow","year":"2006","unstructured":"Swerdlow AJ. Does growth hormone therapy increase the risk of cancer? Nat Clin Pract Endocrinol Metab. 2006;2(10):530\u20131.","journal-title":"Nat Clin Pract Endocrinol Metab"},{"issue":"2","key":"302_CR25","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.jpeds.2010.02.028","volume":"157","author":"P Wilton","year":"2010","unstructured":"Wilton P, Mattsson AF, Darendeliler F. Growth hormone treatment in children is not associated with an increase in the incidence of cancer: experience from KIGS (Pfizer International Growth Database). J Pediatr. 2010;157(2):265\u201370.","journal-title":"J Pediatr"},{"issue":"6","key":"302_CR26","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1210\/jc.2005-2284","volume":"91","author":"EO Reiter","year":"2006","unstructured":"Reiter EO, Price DA, Wilton P, Albertsson-Wikland K, Ranke MB. Effect of growth hormone (GH) treatment on the near-final height of 1258 patients with idiopathic GH deficiency: analysis of a large international database. J Clin Endocrinol Metab. 2006;91(6):2047\u201354.","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Italian Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13052-016-0302-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,12]],"date-time":"2022-07-12T05:09:02Z","timestamp":1657602542000},"score":1,"resource":{"primary":{"URL":"http:\/\/ijponline.biomedcentral.com\/articles\/10.1186\/s13052-016-0302-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,3]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["302"],"URL":"https:\/\/doi.org\/10.1186\/s13052-016-0302-3","relation":{},"ISSN":["1824-7288"],"issn-type":[{"value":"1824-7288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,3]]},"article-number":"93"}}